Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction
Background Persistent airflow obstruction (PAO) in patients with asthma can be difficult to treat. Tezepelumab blocks thymic stromal lymphopoietin, an epithelial cytokine implicated in asthma pathogenesis. This analysis evaluated the efficacy of tezepelumab in patients with severe, uncontrolled asth...
Saved in:
| Main Authors: | Elliot Israel, Mario Castro, Christopher S. Ambrose, Jean-Pierre Llanos, Nestor A. Molfino, Nicole L. Martin, Sandhia S. Ponnarambil, Neil Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2024-11-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/10/6/00164-2024.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tezepelumab for asthma with current or previous smoking habit: Case series
by: Yoshiro Kai, MD, PhD, et al.
Published: (2025-05-01) -
Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs
by: Carlo Lombardi, et al.
Published: (2024-11-01) -
Corrigendum to “Positioning tezepelumab for patients with severe asthma: from evidence to unmet needs”
Published: (2024-12-01) -
Airflow Obstruction in Young Adults in Canada
by: Manal Al-Hazmi, et al.
Published: (2007-01-01) -
miRNAome-metabolome wide association study reveals effects of miRNA regulation in eosinophilia and airflow obstruction in childhood asthmaResearch in context
by: Rinku Sharma, et al.
Published: (2025-02-01)